AGR2 expression as a predictive biomarker for therapy response in esophageal squamous cell carcinoma

Despite multidisciplinary therapy, the prognosis is poor for esophageal squamous cell carcinoma (ESCC). In the locally advanced stage, neoadjuvant chemoradiotherapy (nCRT) followed by surgery could provide survival benefits to some patients. Here, we aimed to identify for tumor therapy response a bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Chih-Hung, Chuang, Han-Ni, Hsiao, Tzu-Hung, Kumar, V. Bharath, Hsu, Chiung-Hung, Huang, Chih-Yang, Lee, Li-Wen, Mao, Chien-Lin, Ko, Jiunn-Liang, Hsu, Chung-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632826/
https://www.ncbi.nlm.nih.gov/pubmed/36327302
http://dx.doi.org/10.1371/journal.pone.0276990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632826/
https://www.ncbi.nlm.nih.gov/pubmed/36327302
http://dx.doi.org/10.1371/journal.pone.0276990

Ejemplares similares